Received Sep 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
Swelling about 4 inches around from the injection site; This non-serious case was reported by a physician and described the occurrence of injection site swelling in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced injection site swelling (Verbatim: Swelling about 4 inches around from the injection site). The outcome of the injection site swelling was resolved. It was unknown if the reporter considered the injection site swelling to be related to Shingrix. It was unknown if the company considered the injection site swelling to be related to Shingrix. Additional Information: GSK Receipt Date: 27-AUG-2025 The physician reported that with the 1st dose of Shingrix the patient did fine and with 2nd dose of Shingrix the patient had swelling about 4 inches around from the injection site. The patient recovered and was glad she got the Shingrix vaccine